Profound Medical Corp (PRN) - Net Assets

Latest as of June 2026: CA$49.73 Million CAD ≈ $35.97 Million USD

Based on the latest financial reports, Profound Medical Corp (PRN) has net assets worth CA$49.73 Million CAD (≈ $35.97 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$62.28 Million ≈ $45.05 Million USD) and total liabilities (CA$12.56 Million ≈ $9.08 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Profound Medical Corp (PRN) strategic asset index to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$49.73 Million
% of Total Assets	79.84%
Annual Growth Rate	N/A
5-Year Change	-17.74%
10-Year Change	500.77%
Growth Volatility	235.43

Profound Medical Corp - Net Assets Trend (2012–2025)

This chart illustrates how Profound Medical Corp's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Profound Medical Corp market cap and net worth.

Annual Net Assets for Profound Medical Corp (2012–2025)

The table below shows the annual net assets of Profound Medical Corp from 2012 to 2025. Also explore PRN shareholders equity momentum to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	CA$66.31 Million ≈ $47.97 Million	+9.75%
2024-12-31	CA$60.42 Million ≈ $43.71 Million	+93.78%
2023-12-31	CA$31.18 Million ≈ $22.56 Million	-40.04%
2022-12-31	CA$52.00 Million ≈ $37.62 Million	-35.49%
2021-12-31	CA$80.62 Million ≈ $58.32 Million	-17.19%
2020-12-31	CA$97.35 Million ≈ $70.42 Million	+581.32%
2019-12-31	CA$14.29 Million ≈ $10.34 Million	-26.91%
2018-12-31	CA$19.55 Million ≈ $14.14 Million	+73.84%
2017-12-31	CA$11.25 Million ≈ $8.13 Million	+1.88%
2016-12-31	CA$11.04 Million ≈ $7.98 Million	+9.70%
2015-12-31	CA$10.06 Million ≈ $7.28 Million	+635.46%
2014-12-31	CA$1.37 Million ≈ $989.71K	+104.57%
2013-12-31	CA$-29.95 Million ≈ $-21.67 Million	-85.24%
2012-12-31	CA$-16.17 Million ≈ $-11.70 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Profound Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 27064820300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	CA$323.25 Million	487.46%
Other Comprehensive Income	CA$5.02 Million	7.56%
Other Components	CA$25.26 Million	38.10%
Total Equity	CA$66.31 Million	100.00%

Profound Medical Corp Competitors by Market Cap

The table below lists competitors of Profound Medical Corp ranked by their market capitalization.

Company	Market Cap
RideNow Group, Inc. NASDAQ:RDNW	$219.74 Million
AURORA EIENDOM NK 75 F:IL7	$219.83 Million
Global Atomic Corp TO:GLO	$219.89 Million
Crane Harbor Acquisition Corp. - Class A Ordinary Shares NASDAQ:CHAC	$220.06 Million
Ratnaveer Precision Engineering Ltd NSE:RATNAVEER	$219.65 Million
Udaipur Cement Works Limited NSE:UDAICEMENT	$219.63 Million
Ultra Chip TWO:3141	$219.59 Million
Paramount Communications Limited NSE:PARACABLES	$219.49 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Profound Medical Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 60,422,000 to 66,313,099, a change of 5,891,099 (9.7%).
Net loss of 43,315,210 reduced equity.
Share repurchases of 42,444,000 reduced equity.
New share issuances of 42,436,000 increased equity.
Other comprehensive income increased equity by 2,273,854.
Other factors increased equity by 46,940,455.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CA$-43.32 Million	-65.32%
Share Repurchases	CA$42.44 Million	-64.01%
Share Issuances	CA$42.44 Million	+63.99%
Other Comprehensive Income	CA$2.27 Million	+3.43%
Other Changes	CA$46.94 Million	+70.79%
Total Change	CA$-	9.75%

Book Value vs Market Value Analysis

This analysis compares Profound Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.79x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	CA$-74.62	CA$8.31	x
2013-12-31	CA$-138.22	CA$8.31	x
2014-12-31	CA$6.31	CA$8.31	x
2015-12-31	CA$4.25	CA$8.31	x
2016-12-31	CA$2.66	CA$8.31	x
2017-12-31	CA$1.83	CA$8.31	x
2018-12-31	CA$1.95	CA$8.31	x
2019-12-31	CA$1.29	CA$8.31	x
2020-12-31	CA$5.63	CA$8.31	x
2021-12-31	CA$3.94	CA$8.31	x
2022-12-31	CA$2.50	CA$8.31	x
2023-12-31	CA$1.47	CA$8.31	x
2024-12-31	CA$2.44	CA$8.31	x
2025-12-31	CA$2.19	CA$8.31	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Profound Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -65.32%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -264.44%
• Asset Turnover: 0.12x
• Equity Multiplier: 2.12x
Recent ROE (-65.32%) is above the historical average (-106.98%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	0.00%	0.00%	0.00x	0.00x	CA$-7.52 Million
2013	0.00%	0.00%	0.00x	0.00x	CA$-11.22 Million
2014	-599.66%	0.00%	0.00x	1.08x	CA$-8.34 Million
2015	-117.28%	0.00%	0.00x	1.52x	CA$-12.81 Million
2016	-110.05%	0.00%	0.00x	1.60x	CA$-13.25 Million
2017	-133.10%	-305.19%	0.22x	1.97x	CA$-16.09 Million
2018	-77.98%	-797.88%	0.06x	1.75x	CA$-17.20 Million
2019	-141.32%	-477.18%	0.14x	2.09x	CA$-21.62 Million
2020	-22.21%	-296.03%	0.07x	1.07x	CA$-31.36 Million
2021	-38.08%	-446.66%	0.08x	1.08x	CA$-38.76 Million
2022	-55.13%	-429.11%	0.10x	1.24x	CA$-33.87 Million
2023	-91.63%	-396.85%	0.16x	1.41x	CA$-31.69 Million
2024	-46.04%	-260.45%	0.15x	1.16x	CA$-33.86 Million
2025	-65.32%	-264.44%	0.12x	2.12x	CA$-49.95 Million

Industry Comparison

This section compares Profound Medical Corp's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $1,119,343
Average return on equity (ROE) among peers: -90.06%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Profound Medical Corp (PRN)	CA$49.73 Million	0.00%	0.25x	$219.66 Million
Aurora Spine Corp (ASG)	$5.57 Million	-42.36%	0.90x	$8.47 Million
MedX Health Corp (MDX)	$-3.63 Million	0.00%	0.00x	$11.86 Million
NuGen Medical Devices Inc (NGMD)	$-5.67 Million	0.00%	0.00x	$2.46 Million
Perimeter Medical Imaging AI Inc (PINK)	$7.42 Million	-225.80%	0.34x	$27.03 Million
Therma Bright Inc (THRM)	$223.97K	-279.81%	4.13x	$1.89 Million
Theralase Technologies Inc. (TLT)	$6.32 Million	-82.45%	0.12x	$41.55 Million
VentriPoint Diagnostics Ltd (VPT)	$-2.40 Million	0.00%	0.00x	$12.22 Million

About Profound Medical Corp

TO:PRN Canada Medical Devices

Market Cap

$219.66 Million

CA$303.65 Million CAD

Market Cap Rank

#16294 Global

#495 in Canada

Share Price

CA$8.31

Change (1 day)

+0.97%

52-Week Range

CA$5.95 - CA$12.11

All Time High

CA$35.63